Global Blood Therapeutics Stock Price

-1.75 (-2.86%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Global Blood Therapeutics Inc GBT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.75 -2.86% 59.44 13:19:39
Close Price Low Price High Price Open Price Previous Close
58.16 61.97 61.66 61.19
Bid Price Ask Price Spread News
59.41 59.68 0.27 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
4,803 407,521 $ 59.65 $ 24,309,579 870,204 39.95 - 87.54
Last Trade Time Type Quantity Stock Price Currency
13:19:39 31 $ 59.41 USD

Global Blood Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.65B 61.36M 53.09M $ 2.11M $ - -4.56 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Global Blood Therapeutics News

Date Time Source News Article
10/12/202008:00GlobeNewswire Inc.GBT Receives Rare Impact Award for Innovation from the..
10/07/202017:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
10/05/202019:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
10/05/202008:00GlobeNewswire Inc.GBT Announces New Employment Inducement Grants
9/14/202018:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
9/09/202008:00GlobeNewswire Inc.GBT and Sickle Cell Disease Association of America to Host..
9/08/202016:05GlobeNewswire Inc.GBT and Biopharma-MEA Enter Agreement to Distribute Oxbryta®..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GBT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week58.6463.6558.1661.73788,2010.801.36%
1 Month54.1664.48951.5158.39790,1095.289.75%
3 Months70.5672.7951.5159.85766,179-11.12-15.76%
6 Months69.6585.0051.5165.83811,192-10.21-14.66%
1 Year48.6487.5439.9565.44931,86210.8022.2%
3 Years32.4087.5429.95553.07957,77927.0483.46%
5 Years49.5287.5412.2444.62835,3739.9220.03%

Global Blood Therapeutics Description

Global Blood Therapeutics Inc operates in the healthcare sector of the United States. It discovers and develops novel therapeutics to address blood-based disorders. GBT440, its lead drug candidate targets the underlying mechanism of red blood cell (RBC) sickling, which provides the potential to treat sickle cell disease. GBT440. an oral, once-daily therapy arrests abnormal hemoglobin polymerization, the underlying mechanism of RBC sickling. In addition, the company is engaged in other research and development activities targeted at hereditary angioedema and owns exclusively licensed rights to its portfolio of product candidates in the United States, Europe, and other major markets.
Your Recent History
Global Blo..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201020 17:34:46